4/11
07:00 am
ftre
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
Low
Report
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
3/22
07:33 am
ftre
Fortrea Holdings Inc. (NASDAQ: FTRE) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $43.00 price target on the stock.
Medium
Report
Fortrea Holdings Inc. (NASDAQ: FTRE) is now covered by analysts at Robert W. Baird. They set a "neutral" rating and a $43.00 price target on the stock.
3/11
06:30 am
ftre
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
Medium
Report
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
3/11
06:30 am
ftre
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
Low
Report
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
2/20
04:05 pm
ftre
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
Low
Report
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
2/20
07:00 am
ftre
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
Low
Report
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
1/29
07:00 am
ftre
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
Medium
Report
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call